[41] On May 4, 2013, De Standaard reported that a press relations (PR) agency working for Alexion had helped the boy's parents communicate their story to the press. Baidu | Specialty drugs in the United States-Wikipedia. To install click the Add extension button. The cover is visually disturbing. Tesla, Inc. | PepsiCo | [11] The stock is up roughly 800% in the last five years and is currently trading at 46 times estimated earnings. 2011 übernahm Alexion Taligen Therapeutics (Cambridge, Massachusetts) und gründete die Translational Medicine Group, um neue Produktkandidaten schneller in die klinische Prüfung bringen zu können. O’Reilly Auto Parts | It will enhance any encyclopedic page you visit with the magic of the WIKI 2 technology. ANSYS | Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. Maxim Integrated | Trụ sở chính: New Haven, Connecticut, Hoa Kỳ: Nhân viên chủ chốt. MercadoLibre | Alexion Pharmaceuticals ist ein biopharmazeutisches Unternehmen mit Sitz in Boston. CoStar Group | At LogoLynx.com find thousands of logos categorized into thousands of categories. Alphabet | NetApp | Insurance companies have generally been willing to pay high prices for such drugs; since few of their customers need the drugs, a high price does not significantly impact the insurance companies' outlays. [34] In the case of the rarest diseases that afflict fewer than 10,000 people, biotech companies who own the only approved drugs to treat those diseases "can charge pretty much whatever they want." [9][10] Bell served as the company's CEO until 2015. Western Digital | Ludwig Norbert Michel Hantson (born August 1962) is a Belgium businessman, the CEO of Alexion Pharmaceuticals since March 2017. Diese Seite wurde zuletzt am 9. I use WIKI 2 every day and almost forgot how the original Wikipedia looks like. View milestones that have marked our growth. Kanuma, which Alexion acquired in its acquisition of Synageva, was approved in 2015 to treat lysosomal acid lipase deficiency, a fatal genetic disorder that cause fatty material to build up in blood vessel walls, the liver, and other tissues. Alexion is putting pressure on to governments to receive their payments from the public purse. Alexion moved back to New Haven following the completion of New Haven's Downtown Crossing project in December 2015. Skyworks Solutions | Alexion, Aralık 2015'te New Haven'ın Downtown Crossing projesinin tamamlanmasının ardından New Haven'a geri döndü. Microsoft | Alexion Pharmaceuticals … [25], In April 2018, Alexion announced the acquisition of Wilson Therapeutics for $855 million. By 2010 Alexion Pharmaceuticals's Soliris, was considered to be the most expensive drug in the world. Revenue was impacted by higher unit volumes for Soliris (up 40%), and a decreased average price related to rebates in Europe. recent move to acquire Portola for about $1.4 billion, are leading in the "wrong direction." It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. At the time Proliferon's annual revenue was about $2.5 million and its assets were valued at $2.1 million. Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell. The gag order was revoked by the end of September 2013,[48] but the case was still pending in March 2015. Vertex Pharmaceuticals | [12], In April 2011, Alexion was added to the NASDAQ-100, a group composed of the 100 largest non-financial stocks traded on the NASDAQ; with a market value of US$8.5 billion it replaced Genzyme Corporation. In October 2015, Alexion's second drug, Strensiq (asfotase alfa), was approved by the US FDA. As a result, Alexion hires public relations firms to help families institute campaigns to pressure their governments to pay for the drug. [17][18], In December 2020, AstraZeneca announced it would be buying the company; at announcement the deal was worth $39 billion. Paychex | Due to the niche nature of its market and the high cost of Soliris, the company has enjoyed a high profit margin.[25]. Fiserv | Alexion Pharmaceuticals, Inc., is a global biopharmaceutical company focused on delivering life-transforming therapies for patients with severe, ultra-rare diseases. Licensing. Alexion, 2006'dan … Alexion Pharmaceuticals Permission (Reusing this file) See below. [43][44] Several politicians stated that the company was attempting to 'blackmail' the government, charges which Alexion denied. Alexion moved back to New Haven following the completion of New Haven's Downtown Crossing project in December 2015. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England. Verisign | Het bedrijf ontwikkelde Soliris tegen het hemolytisch-uremisch syndroom en Paroxismale nachtelijke hemoglobinurie. $ALXN Stock Analysisð, should we buy Alexion Pharmaceuticals? Ulta Beauty | Vertex Pharmaceuticals es una compañía estadounidense ubicada en Boston, Massachusetts.. Fue fundada en 1989 por Joshua Boger [2] y Kevin J. Kinsella. Comcast | But if it had worked for arthritis, Alexion would likely have had to charge a much lower price for this use, as it would have to compete against drugs that cost a mere $20,000." Leonard Bell David R. Brennan(interim CEO) Sản phẩm: Soliris: Doanh thu: US$2.6 bil (2015) Lợi nhuận kinh doanh. [6][11] The price of the drug is so high that very few individuals can pay the price. The company is also involved in immune system research related to autoimmune diseases. Home; News; Random Article; Install Wikiwand; Send a suggestion; Uninstall Wikiwand; Our magic isn't perfect. Alexion évalue actuellement des indications potentielles pour le traitement d’autres maladies ultra-rares et graves au-delà de l’HPN et du SHUa, et développe d’autres médicaments particulièrement innovants en matière de biotechnologie, et à la croisée de multiples aires thérapeutiques. IDEXX Laboratories | Illumina | Sirius XM Holdings | Das Unternehmen ist auf Orphan-Arzneimittel zur Behandlung von seltenen und sehr seltenen Krankheiten spezialisiert. [25] However, by September 2013 quarterly sales of Soliris topped $400 million. It employs around 2,400 people worldwide. [10] In 2000, Alexion moved its headquarters from New Haven to Cheshire, Connecticut. [3] Vertex, fue una de las primeras empresas de biotecnología en usar una estrategia enfocada al diseño racional de fármacos, en lugar del diseño de estos a partir de una química combinatoria.. Para el 2004, su línea de producción estaba enfocada en … Elliott argues that Alexion management's actions, including the o.m. Cerner Corporation | [25] "The success of specialty drugs for rare diseases comes at a time when the traditional drug business of selling medicines to the masses is in decline...Specialty drugs have gotten more expensive than anyone imagined. He served as a Director of Alexion since July 2014 and as Interim Chief Executive Officer of Alexion from December 2016 to March 2017. Xilinx | In March 2017 Arbutus signed another license for its liposome delivery technology, this … Transferred from de.wikipedia to Commons by Wdwdbot using script bot_filetrans.pl (r46M). The original description page was here . [4][5] The company is also involved in immune system research related to autoimmune diseases. [8] [9] Bell served as the company's CEO until 2015. Bell served as the company's CEO until 2015. For faster navigation, this Iframe is preloading the Wikiwand page for Alexion Pharmaceuticals. This move was aimed to diversify Alexion's hematology, neurology, and critical care commercial portfolio with Portola's Factor Xa inhibitor reversal agent. All following user names refer to de.wikipedia. Alexion started selling Soliris in 2008 making $295 million in 2007 with its stock price rising to 130% in 2010. Das Unternehmen ist auf Orphan-Arzneimittel zur Behandlung von seltenen und sehr seltenen Krankheiten spezialisiert. This image or logo only consists of typefaces, individual words, slogans, or simple geometric shapes. CDW Corporation | History. KLA-Tencor | Bell, 2015 yılına kadar şirketin CEO'su olarak görev yaptı. However, on June 12, Alexion received a court gag order against Pharma, preventing it from communicating its investigation. Incyte | In addition, much of the research for the development of Soliris originates from publicly funded universities. Additionally, big pharmaceutical companies have tended to ignore these markets, creating a niche with minimal competition for Alexion. Congratulations on this excellent venture⦠what a great idea! PayPal | Dollar Tree | Alexion Pharmaceuticals; Alexion Pharmaceuticals: Loại hình. Elle est cotée en bourse : Nasdaq Stock Market - … That's it. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. ASML | Netflix | These are not eligible for copyright alone because they are not original enough, and thus the logo is considered to be in the public domain. [23], In May 2015, Alexion announced plans to purchase the Lexington firm Synageva BioPharma, a maker of rare disease treatments, in an $8.4 billion stock-and-cash deal. Press release - Coherent Market Insights - Orphan Drugs Market | Acorda Therapeutics, Actelion Pharmaceuticals Ltd., Amgen, Alexion Pharmaceuticals, Baxter international - published on openPR.com Electronic Arts | Alexion Pharmaceuticals ist ein biopharmazeutisches Unternehmen mit Sitz in Boston. There is an ethical question as to the pricing of the drug and the ethics of the drug manufacturer. Gilead Sciences | Align Technology | It employs around 2,400 people worldwide. ホーム ; »; アレクシオンについて » 会社概要; 会社概要. Facebook | Lululemon Athletica | Trip.com Group | Elle est basée à Cheshire, au Connecticut. Alexion Pharmaceuticals Inc. on Ameerika ravimifirma. See insights on Alexion Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. [4], Am 12. The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors: Proliferon Inc(Acq 2000, restructured into Alexion Antibody Technologies Inc), As of 2017 Alexion Pharmaceuticals shares are mainly held by 735 institutional investors (Fidelity Investments, T. Rowe Price, BlackRock and others[33]), Alexion has employed a strategy of developing drugs to combat rare diseases. David Brennan, a current board member, became interim CEO. Adobe Inc. | Dit geneesmiddel kost vanwege het lage verbruik 385.000 euro per patiënt per jaar. Alexion has operations in Belgium to serve patients locally. In December 2019, Alexion's board unanimously rejected a recommendation by Elliott to immediately launch a proactive sale.[32]. Ross Stores | Pharmaceutical Research and Manufacturers of America, https://ir.alexion.com/news-releases/news-release-details/alexion-reports-fourth-quarter-and-full-year-2019-results#:~:text=BOSTON%20%2D%2D(BUSINESS%20WIRE)%2D%2D,percent%20increase%20compared%20to%202018, "Alexion Pharmaceuticals 2017 Annual Report Form (10-K)", "Alexion Submits Application for Soliris", "Alexion Pharmaceuticals on the Forbes World's Most Innovative Companies List", "Everything you need to know about the $8.4B acquisition of Synageva", "Photos of Alexion Pharmaceuticals World HQ Dedication", "Alexion Exits New Haven For Boston, Agrees To Repay Millions In State Aid", "More Support for Long-Term Plavix to Improve Stent Safety", "How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse", "Alexion to Buy Synageva for $8.4 Billion", "Alexion treating Europe's E coli victims", "Alexion Pharmaceuticals, Inc. to Join the NASDAQ-100 Index Beginning April 4, 2011", "Teva wins controversial PhRMA bid despite protests from branded rivals - FiercePharma", "Alexion's Board of Directors Announces New Leadership Appointments | Alexion Pharmaceuticals, Inc", "Alexion Pharma names former Baxalta chief Ludwig Hantson CEO", "Alexion closing RI manufacturing facility, 250 losing jobs", https://ir.alexion.com/news-releases/news-release-details/astrazeneca-acquire-alexion-accelerating-companys-strategic-and, "AstraZeneca makes $39bn swoop for rare diseases firm Alexion", "Alexion Buys Calif. Firm;Proliferon acquired in $41 million deal", "Securities and Exchange Commission Alexion 8-K 2000 Report", "Alexion to Pay as Much as $1.08 Billion to Buy Enobia Pharma", "How Genzyme became a source of biotech executives", "Alexion Puts Its Soaring Stock Price to Good Use", "Biotech M&A rolls on as Alexion snaps up Wilson for $855 million", "Alexion to Acquire Wilson Therapeutics for $855M - GEN", "Alexion to Acquire Syntimmune for Up to $1.2B, Expanding Rare Disease Pipeline", "Alexion to buy biotech firm Syntimmune for up to $1.2 billion", https://www.biospace.com/article/alexion-buys-achillion-in-930-million-cash-deal/?s=79, "Elliott Advisors (UK) Limited sent the following letter to the Board of Alexion today", "Alexion Pharmaceuticals, Inc. (ALXN) Ownership Summary", "Soliris® (eculizumab) Approved by FDA for All Patients with Atypical Hemolytic Uremic Syndrome (aHUS)", "Doctors must tell patients of errors, under new Varadkar law", "High cost of treatment for rare blood disorder needs to be clarified, says NICE in draft guidance", "Viktor (7) moet elke twee weken infuus krijgen van 9.000 euro", "Pr-bureau van farmabedrijf adviseerde ook ouders Viktor", "Farmabedrijf Alexion heeft Viktor "gebruikt, "Farmabaas fluit Alexion terug in zaak-Viktor", "Detiège: "Dit is chantage van het farmabedrijf, "Medicijn Viktor vanaf juli terugbetaald", "Contract van Onkelinx met farmareus opent doos van Pandora", "Alexion Pharmaceuticals Stock Jumps on FDA Approval of Soliris", "Alexion Pharma (ALXN) Receives New Japanese Patent for Soliris", "Biotech blastoff: Synageva up 112% on $8B Alexion deal", "Alexion Pharmaceuticals, Inc. - Annual Report", Pharmaceutical companies of the United States. Since 2006, Alexion has been a supporter of healthcare research and quality studies at Duke University for aspirin and Clopidogrel (trade name Plavix). In Canada, access to the drug is mostly through private clinics; groups such as the Canadian Association of PNH Patients are lobbying to change that. Exelon | [16], In September 2017, Alexion announced that it would be closing its Smithfield, RI manufacturing facility. Alexion wurde 1992 unter anderem von Leonard Bell gegründet, einem Professor für Innere Medizin und Pathologie an der Yale University. Xcel Energy | Liberty Global | Bell se desempeñó como director ejecutivo de la empresa hasta 2015. Splunk | Alexion Pharmaceuticals, 1992 yılında New Haven, Connecticut'taki Science Park'ta Steven Squinto ve Leonard Bell tarafından kuruldu. Intuitive Surgical | Intel | The boy's medicine cost 9,000 euros every two weeks. Marriott International | Das Unternehmen ist auf Orphan-Arzneimittel zur Behandlung von seltenen und sehr seltenen Krankheiten spezialisiert. Pour plus d’information à propos d’Alexion, consulter : https://www.alexion.com. [11][25], Before the Synageva purchase announcement, Alexion was valued at $34 billion. Amgen | Alexion CEO, Leonard Bell, cited Proliferon's ability to produce an "unlimited amount of antibodies" as the reason for the acquisition. Biogen | [34] It costs £340,200 per year for treatment in the UK[38][39] and $500,000 a year in Canada. Eculizumab wird in zahlreichen weiteren Indikationen (Antibody Mediated Rejection (AMR) - Living and Deceased Donor, Delayed Graft Function (DGF), Relapsing Neuromyelitis Optica (NMO), Severe and Refractory Myasthenia Gravis (MG), Shiga-toxin E. coli-Related (STEC) HUS) untersucht. United Airlines Holdings | [36], In September 2011, the FDA officially approved the use of Soliris as a treatment for atypical hemolytic-uremic syndrome in both adults and children. In December 2011, Alexion acquired Montreal-based Enobia Pharma Corp, the developer of asfotase alfa, a drug used to treat the genetic disorder hypophosphatasia. Upon completion of merger, Alexion shareholders will own 15% of combined company.[19][20]. [14], In December 2016, Alexion's board of directors announced new leadership. BioMarin Pharmaceutical | [49] In November 2017 the company received a patent for Soliris from the Japanese Patent Office.[50]. T-Mobile US | Contact média. Applied Materials | Đại chúng: Mã niêm yết: NASDAQ: ALXN; NASDAQ-100 component; S&P 500 Component; Ngành nghề: Dược phẩm: Thành lập: 1992: Người sáng lập: Leonard Bell, M.D. In 2019 maakte dit geneesmiddel … Regeneron Pharmaceuticals | Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Fastenal | [11] It also represented a valuation of about ten times projected peak sales, double what is typical for the biotech industry. 2000 yılında, Alexion merkezini New Haven'dan Cheshire, Connecticut'a taşıdı . David R. Brennan is Chairman of Alexion’s Board of Directors. [30], In May 2020, Alexion announced an agreement to acquire Portola Pharmaceuticals for $18 per share using cash. Alexion Pharmaceuticals est une entreprise de biotechnologie américaine spécialisée dans la recherche et le développement de produits thérapeutiques destinés au traitement des maladies hématologiques et cardiovasculaires, des maladies auto-immunes et des cancers et produisant notamment l'Éculizumab, un anticorps. Acquisition related costs fell significantly from $22 million to just $5 million. [31] In May 2020, the hedge fund Elliott Management Corporation, which acquired a position in Alexion in 2017, had - again - pushed for Alexion to sell itself, months after the drugmaker had rejected the hedge fund's earlier demand. Starbucks | Cadence Design Systems | If you are contacted in this manner, please be aware that it is fraudulent, and please do not provide any information or money to these individuals. Alexion wird an der NASDAQ gehandelt und ist im NASDAQ-100 gelistet. Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell. CSX Corporation | Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell. Alexion wird an der NASDAQ gehandelt und ist im NASDAQ-100 gelistet. Alexion Pharmaceuticals; 公司類型 : 上市公司: 股票代號: NASDAQ：ALXN; NASDAQ-100 component; S&P 500 Component; ISIN: 成立: 1992: 創辦人: Leonard Bell: 代表人物: Max E. Link 董事長 David L. Hallal CEO: 總部: 美國康涅狄格州 柴郡: 产业: 製藥: 產品: Soliris: 營業額: US$ 11.51346億（2013） 37%: 息税前利润: US$ 5.28010億（2013） 净利润: US$ 2.52895億（2013） 總資產: US$ 33.17696億（2013） 資 … Walgreens Boots Alliance | At no time will we ask candidates for fees associated with obtaining software, nor do we provide employees with a cashier’s check to purchase new equipment. From 2006 to 2012, he served as Chief Executive Officer and Executive Director of AstraZeneca PLC, one of the world's largest pharmaceutical companies. Mr. Brennan worked for AstraZeneca in increasing roles of … Charter Communications | You could also do it yourself at any point in time. Ludwig N. Hantson-Wikipedia. Would you like Wikipedia to always look as professional and up-to-date? En 2000, Alexion trasladó su sede de New Haven a Cheshire, Connecticut .Alexion se mudó de regreso a New Haven luego de la finalización del proyecto Downtown Crossing de New Haven en diciembre de … Cognizant Technology Solutions | 2.500 Mitarbeiter. Mondelēz International | Apple | [11] In 2016, the company became a member of the Pharmaceutical Research and Manufacturers of America (PhRMA). Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. In 2000, Alexion purchased Proliferon Inc., a San Diego, California-based development-stage biopharmaceutical firm, for US$41 million in Alexion stock. Lam Research | [47], In October 2017 the FDA approved the use of Soliris to treat adult patients with generalized myasthenia gravis (gMG). Nvidia | Alexion Pharmaceuticals | Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). You can help our automatic cover photo selection by reporting an unsuitable photo. Alexion is well on the way to developing a second very high price and high margined drug. Im Jahr 2018 verlagerte das Unternehmen seinen Hauptsitz von New Haven in Connecticut nach Boston. [5] It has been approved for use in Canada, the European Union, Japan, and the United States; however, availability in Canada is limited. Soliris was considered a treatment option because of its effectiveness in treating Atypical hemolytic uremic syndrome, an illness similar to the one caused by the EHEC infection. Vertex … BOSTON & BLUE BELL, Pa.--(BUSINESS WIRE)--Oct. 16, 2019-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) today announced that they have entered into a definitive agreement for Alexion to acquire Achillion, a clinical-stage biopharmaceutical company focused on the development of oral small molecule Factor D inhibitors to … [7], In September 2017, Alexion announced it would be moving its headquarters to Boston, Massachusetts, in mid-2018.[8]. Ebenfalls 2011 übernahm Alexion Enobia Pharma (Montreal, Kanada) und deren Rechte an Asfotase Alpha, einem Produktkandidaten zur Behandlung von Hypophosphatasie. [40], In April and May 2013, a controversy arose in Belgium when the media revealed that the government had refused to pay for a seven-year-old boy's treatment because Soliris was too expensive. Alexion Pharmaceuticals ist ein biopharmazeutisches Unternehmen mit Sitz in Boston. Belgium. [5][3], 2020 erwirtschaftete das Unternehmen einen Umsatz von 6,1 Mrd. It also employes about 3,000 people worldwide. Texas Instruments | At the same time, Pharma opened a court case against Alexion Pharma Belgium. Costco | Business data for Alexion Pharmaceuticals. [52] R&D spending reached a record high of $317 million in 2013 up 83% from the previous year. Februar 2021 um 21:28 Uhr bearbeitet. Fox Corporation | More than half of people with aHUS end up dying of it as a result of damage to vital organs/organ failure (usually involving the kidneys) caused by uncontrolled complement activation. Alexion has grown from a biotech startup to a leading global biopharmaceutical company focused on rare disease. [9], Alexion received U.S. Food and Drug Administration (FDA) approval for Soliris in 2007. In 2000, Alexion moved its headquarters from New Haven to Cheshire, Connecticut.Alexion moved back to New Haven following the completion of New Haven's Downtown Crossing project in December 2015. Historia . The Kraft Heinz Company | Alexion Pharmaceuticals fue fundada en 1992 en Science Park en New Haven, Connecticut por Steven Squinto y Leonard Bell. The prices charged have a very high margin above the cost price. Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). [28][29], In October 2019, the business announced it would acquire Achillion Pharmaceuticals for $930 million, boosting its immune system disease pipeline. Seagen | … eBay | … Activiteiten. Expedia | Booking Holdings | Automatic Data Processing | Alexion Pharmaceuticals (NASDAQ: ALXN) é uma empresa farmaceutica americana, sediada em Connecticut Este artigo sobre uma empresa é um esboço. Micron Technology | Amazon.com | [46][47], Pharma, the Belgian pharmaceutical industry's association, opened an internal investigation into the affair, for possible breach of the association's ethical standards by Alexion. It is used to treat hypophosphatasia, a rare metabolic disorder. [21][22] The company has since been renamed Alexion Antibody Technologies Inc. Dexcom | Alexion Pharmaceuticals has 3,082 employees across 23 locations and $6.07 B in annual revenue in FY 2020. Esta página foi editada pela última vez às 19h56min de 17 de setembro de 2020. In February 2016, the … Zoom Video Communications, atypischen Hämolytisch-Urämischen Syndroms, refraktären AChR-AK-positiven generalisierten Myasthenia Gravis, Molybdän-Cofaktor-Defizienz (MoCD) Type A, Alexion Reports Fourth Quarter and Full Year 2020 Results, Alexion Pharmaceuticals Inc. moving headquarters to Boston, https://de.wikipedia.org/w/index.php?title=Alexion_Pharmaceuticals&oldid=208640957, „Creative Commons Attribution/Share Alike“. The trials failed. [11] Alexion estimates that the drug could eventually have annual sales of more than $1 billion. [42] It was also reported that the parents had believed their benefactor was a Dutch organization for patients, and that the PR agency acted with permission from Alexion. Take-Two Interactive | Paccar | [3] Alexion hat mehr als 50 Niederlassungen, darunter Tokio, Sydney, Zürich und München und beschäftigt weltweit ca. Copart | Microchip Technology | Products: Soliris, Kanuma, Strensiq Revenue: US$ 2.604 bil (2015) Operating Income: US$ 536.671 mil (2015) Net income: US$ 144.385 mil (2015) Total assets: US$ 13.133230 bil (2015) Total equity: US$ 8.258616 bil (2015) Number of employees: 3,000 (2015) Website: www.alexion.com. The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Alexion Pharmaceuticals is een Amerikaans farmaceutisch bedrijf gespecialiseerd in weesgeneesmiddelen voor zeldzame aandoeningen. NetEase | Het bedrijf is ook betrokken bij immuunsysteemonderzoek in verband met auto … US-Dollar, die fast ausschließlich auf Soliris (4,1 Mrd. Você pode ajudar a Wikipédia . 29 Alexion Logos ranked in order of popularity and relevancy. Alexion Pharmaceuticals page edits. Cisco | We have created a browser extension. [24] The price represented more than a 135% premium over Synageva's market cap at the time. Applicants should … Analog Devices | The FDA's decision to grant approval received a positive response from the medical community with the director of Pediatric Nephrology at Atlanta's Children's hospital calling it "the most important advance that has been made for patients and families with this disease". The cover is not a good choice . NXP Semiconductors | US-Dollar) beruhen. Alexion Pharmaceuticals Inc. is een Amerikaans farmaceutisch bedrijf dat vooral bekend staat om de ontwikkeling van Soliris , een geneesmiddel dat wordt gebruikt voor de behandeling van de zeldzame aandoeningen atypisch hemolytisch uremisch syndroom (aHUS) en paroxismale nachtelijke hemoglobinurie (PNH). [45] By May 7, 2013 an agreement had been reached to reimburse the medicine. Check Point | It will enhance any encyclopedic page you visit with the magic of the WIKI 2 technology. Verisk Analytics | [13], In April 2015, Bell was replaced as CEO by David Hallal. [1], Activision Blizzard | It was initially approved to treat paroxysmal nocturnal hemoglobinuria, a rare blood disorder. [38][39][40] and US$409,500 a year in the United States (2010). Broadcom Inc. | Citrix | Cintas | Advanced Micro Devices | Synopsys | Alexion wird an der NASDAQ gehandelt und ist im NASDAQ-100 gelistet. Monster Beverage | The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. Este texto é disponibilizado nos termos da licença Atribuição-CompartilhaIgual 3.0 Não Adaptada (CC BY-SA 3.0) da Creative Commons; pode … [6] In 2010, there was an outbreak of hemolytic-uremic syndrome caused by Enterohaemorrhagic Escherichia coli (EHEC) in Germany. Every Dose Matters: George Llado, Alexion Pharmaceuticals | NEXUS '16 Keynote, Alexion Pharmaceuticals: Growth at a Reasonable Price (GARP). "Before testing Soliris for PNH, Alexion tested the drug for rheumatoid arthritis, which afflicts 1 million Americans. Workday | [35] The drug costs roughly $450,000 a year, and is considered the world's most expensive drug. [11] In 2000, Alexion moved its headquarters from New Haven to Cheshire, Connecticut. Intuit | Sales during the first quarter of 2015 were just over US$600 million, and are still on the rise. [26][27] In September the company announced it was to acquire Syntimmune for $1.2 billion - expanding its rare disease offering. Qualcomm | "[34], Alexion's first drug, Soliris, first launched in 2007,[10] used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and Paroxysmal nocturnal hemoglobinuria (PNH). Alexion does not contact candidates via instant messaging or chat tools. [51], In 2013, 36% Alexion's sales originated in the US, down from 37% the previous year; 33% came from Europe, down from 35%; Japan accounted for just over 10%. Since … [37], By 2010 Soliris was considered to be the most expensive drug in the world. Autodesk | [6] In February 2016, the company held the dedication ceremony for its new headquarters in New Haven, Connecticut, not far from the company's starting point in the same city.
Grusel Lost Place,
Axa Mobilitätsgarantie Erfahrung,
Thessaloniki Wetter September,
Besteck Gold Ikea,
Widerspruch Einlegen Rentenversicherung Reha,
Purina Beyond Nassfutter Hund,
Stundenplan Kanti Glarus,